Works matching IS 20458932 AND DT 2022 AND VI 12 AND IP 2
Results: 40
Precapillary pulmonary arterial hypertension in a patient with Proteus syndrome.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12098
- By:
- Publication type:
- Article
Corrigendum for health‐related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12085
- By:
- Publication type:
- Article
Pulmonary hypertension is associated with an increased incidence of cancer diagnoses.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12000
- By:
- Publication type:
- Article
Visibility, wind speed, and dew point temperature are important factors in SARS‐CoV‐2 transmissibility.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12081
- By:
- Publication type:
- Article
TGF‐βreceptormutationsandclinicalprognosisinChinese pediatric patients with idiopathic/hereditary pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12076
- By:
- Publication type:
- Article
Inhaled iloprost induces long‐term beneficial hemodynamicchangesin patientswithpulmonaryarterial hypertension receiving combination therapy.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12074
- By:
- Publication type:
- Article
Outcomes of cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12066
- By:
- Publication type:
- Article
Topotecan reduces sepsis‐induced acute lung injury and decreases the inflammatory response via the inhibition of the NF‐κB signaling pathway.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12070
- By:
- Publication type:
- Article
Epoprostenol‐associated ascites in pulmonary arterial hypertension.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Human pulmonary artery endothelial cells upregulate ACE2 expression in response to iron‐regulatory elements: Potential implications for SARS‐CoV‐2 infection.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12068
- By:
- Publication type:
- Article
Rationale and design of a screening study to detect schistosomiasis‐associated pulmonary hypertension in Ethiopia and Zambia.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12072
- By:
- Publication type:
- Article
Accuracy of Swan‒Ganz catheterization‐based assessment of right ventricular function: Validation study using high‐fidelity micromanometry‐derived values as reference.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12078
- By:
- Publication type:
- Article
Right heart thrombi (RHT) and clot in transit with concomitant PE management: Approach and considerations.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12080
- By:
- Publication type:
- Article
Utilization of risk assessment tools in management of PAH: A PAH provider survey.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12057
- By:
- Publication type:
- Article
BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™in patients with pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12063
- By:
- Publication type:
- Article
NEDD9providesmechanisticinsight into thecoagulopathy of COVID‐19.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12087
- By:
- Publication type:
- Article
Pulmonary hypertensive crisis in children with pulmonary arterial hypertension undergoing cardiac catheterization.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12067
- By:
- Publication type:
- Article
A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2).
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12088
- By:
- Publication type:
- Article
Physical activity and its clinical correlates in chronic thromboembolic pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12048
- By:
- Publication type:
- Article
Examining the impact of pulmonary hypertension on nonprofessional caregivers: A mixed‐methods systematic review.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12077
- By:
- Publication type:
- Article
Critical role for the lung endothelial nonmuscle myosin light‐chain kinase isoform in the severity of inflammatory murine lung injury.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12061
- By:
- Publication type:
- Article
Maternal and fetal outcomes of pregnantwomenwith pulmonary arterial hypertension associated with congenital heart disease in Beijing, China: A retrospective study.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12079
- By:
- Publication type:
- Article
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12055
- By:
- Publication type:
- Article
Real‐world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12090
- By:
- Publication type:
- Article
Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12039
- By:
- Publication type:
- Article
Current status and barriers in pulmonary hypertension care delivery in India: A qualitative analysis.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12094
- By:
- Publication type:
- Article
Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12093
- By:
- Publication type:
- Article
Differentiating pulmonary hypertension associated with protein kinase inhibitors.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12075
- By:
- Publication type:
- Article
CXCL10 levels in diagnosis and improved hemodynamics in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12091
- By:
- Publication type:
- Article
Recognizing pulmonary hypertension following pulmonary thromboendarterectomy: A practical guide for clinicians.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12073
- By:
- Publication type:
- Article
Anunusual case ofCTEPHtreated byBPAin a patient with a single lung after cancer surgery.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Early‐onset and severe pulmonary arterial hypertension due to a novel compound heterozygous association of rare VHL mutations: A case report and review of existing data.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12052
- By:
- Publication type:
- Article
The exercise in pulmonary arterial hypertension (ExPAH) study: A randomized controlled pilot of exercise training and multidisciplinary rehabilitation in pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12069
- By:
- Publication type:
- Article
Echocardiographic characteristics of patients with antisynthetase syndrome.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12084
- By:
- Publication type:
- Article
Meeting abstracts from the 15th international conference on neonatal and childhood pulmonary vascular disease.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12065
- By:
- Publication type:
- Article
The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE).
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12086
- By:
- Publication type:
- Article
Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT).
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12083
- By:
- Publication type:
- Article
Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS‐CoV‐2 infection.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12071
- By:
- Publication type:
- Article
Improved hospitalization rates in a specialty center for heart failure with preserved ejection fraction and pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12002
- By:
- Publication type:
- Article
A dual center and dual vendor comparison study of automated perfusion‐weighted phase‐resolved functional lung magnetic resonance imaging with dynamic contrast‐enhanced magnetic resonance imaging in patients with cystic fibrosis.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 2, p. 1, doi. 10.1002/pul2.12054
- By:
- Publication type:
- Article